Gyre Therapeutics (GYRE) Price to Sales (2010 - 2026)
Powered by 
Analysis
Gyre Therapeutics (GYRE) Price to Sales (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Gyre Therapeutics | 691.38 Mn | 633.98 Mn | 26.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.01 |
| Mar 31, 2026 | 28.27 |
| Dec 31, 2025 | 17.33 |
| Sep 30, 2025 | 22.18 |
| Jun 30, 2025 | 22.45 |
| Mar 31, 2025 | 30.67 |
| Dec 31, 2024 | 37.47 |
| Sep 30, 2024 | 42.20 |
| Jun 30, 2024 | 40.45 |
| Mar 31, 2024 | 54.95 |
| Dec 31, 2023 | 72.48 |
| Sep 30, 2023 | 0.57 |
| Jun 30, 2023 | 0.45 |
| Mar 31, 2023 | 0.32 |
| Dec 31, 2022 | 0.20 |
| Mar 31, 2022 | 26.17 |
| Dec 31, 2021 | 11.71 |
| Sep 30, 2021 | 56.10 |
| Jun 30, 2021 | 119.92 |
| Mar 31, 2021 | 107.65 |